Objective: To evaluate whether measuring pregnancy-associated plasma protein A (PAPP-A) and free β-human chorionic gonadotrophin (β-hCG) before 10 weeks of gestation affect the association between these biomarkers and adverse pregnancy outcomes.
Methods: Singleton pregnant women (9450) who attended the prenatal screening program, Aarhus University Hospital, Denmark, were included. Maternal serum levels of PAPP-A and free β-hCG were measured between week 8 and 13 weeks and 6 days. The risk of preterm delivery (<37 weeks) and small for gestational age (SGA) (
Results: A stronger association between low PAPP-A and SGA was found with early serum sampling compared to late, but the difference was not statistically significant [odds ratio (OR) 3.2 vs 1.8; P value = 0.11]. This difference did not apply to PAPP-A and preterm delivery. For free β-hCG, a stronger association with preterm delivery was found with early testing (OR 1.9 vs 1.1; P value = 0.31), whereas this difference was not found regarding SGA.
Conclusion: Biochemical testing before 10 weeks does not affect the association between low PAPP-A and free β-hCG and adverse pregnancy outcomes. Whether the association is actually stronger with early testing, requires further study.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/pd.2671 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!